- Home
- SA vs OPK Comparison
SA vs OPK Comparison
Compare SA & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SA
- OPK
- Stock Information
- Founded
- SA 1979
- OPK 2007
- Country
- SA Canada
- OPK United States
- Employees
- SA N/A
- OPK N/A
- Industry
- SA Precious Metals
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- SA Basic Materials
- OPK Health Care
- Exchange
- SA Nasdaq
- OPK Nasdaq
- Market Cap
- SA 1.8B
- OPK 1.0B
- IPO Year
- SA N/A
- OPK 1995
- Fundamental
- Price
- SA $20.01
- OPK $1.38
- Analyst Decision
- SA
- OPK Buy
- Analyst Count
- SA 0
- OPK 4
- Target Price
- SA N/A
- OPK $2.75
- AVG Volume (30 Days)
- SA 1.0M
- OPK 1.9M
- Earning Date
- SA 11-13-2025
- OPK 11-06-2025
- Dividend Yield
- SA N/A
- OPK N/A
- EPS Growth
- SA N/A
- OPK N/A
- EPS
- SA N/A
- OPK N/A
- Revenue
- SA N/A
- OPK $664,029,000.00
- Revenue This Year
- SA N/A
- OPK N/A
- Revenue Next Year
- SA N/A
- OPK $0.84
- P/E Ratio
- SA N/A
- OPK N/A
- Revenue Growth
- SA N/A
- OPK N/A
- 52 Week Low
- SA $9.40
- OPK $1.11
- 52 Week High
- SA $20.55
- OPK $2.04
- Technical
- Relative Strength Index (RSI)
- SA 55.08
- OPK 51.10
- Support Level
- SA N/A
- OPK $1.34
- Resistance Level
- SA $19.01
- OPK $1.44
- Average True Range (ATR)
- SA 0.59
- OPK 0.04
- MACD
- SA -0.47
- OPK -0.00
- Stochastic Oscillator
- SA 98.47
- OPK 45.00
About SA Seabridge Gold Inc. (Canada)
Seabridge Gold Inc is a development stage company involved in the exploration, and development of gold properties sited in North America. The company's principal projects include the Kerr-Sulphurets-Mitchell property located in British Columbia, the Courageous Lake property located in the Northwest Territories, and Iksut Property located in northwestern British Columbia, and the 3 Aces Project in southeast Yukon. The company has various other mineral resource projects throughout North America.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.